More recently, studies have identified CKAP2L as a prognostic marker of various human cancer, including esophageal squamous cell carcinoma, hepatocellular carcinoma, lung adenocarcinoma, and clear cell renal carcinoma [15, 16, 17, 18]. Here, CKAP2L is linked to clear cell renal carcinoma.